nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement of Sponsors
|
|
|
2008 |
34 |
1S |
p. viii- 1 p. |
artikel |
2 |
Advanced fluorescence microscopy methods illuminate the transfection pathway
|
De Smedt, Stefaan C. |
|
2008 |
34 |
1S |
p. S20- 1 p. |
artikel |
3 |
A metabolomics platform for discovery and diagnosis
|
Siuzdak, Gary |
|
2008 |
34 |
1S |
p. S22- 1 p. |
artikel |
4 |
Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure ionization-mass spectrometry
|
Haapala, M. |
|
2008 |
34 |
1S |
p. S34- 1 p. |
artikel |
5 |
A new method for on-line measurement of moisture content during fluid-bed granulation
|
Seppälä, K. |
|
2008 |
34 |
1S |
p. S32- 1 p. |
artikel |
6 |
Anti-leishmanial activity of betulin derivatives
|
Alakurtti, S. |
|
2008 |
34 |
1S |
p. S37- 1 p. |
artikel |
7 |
Application of superheated steam for rapid modification of drug particle surfaces
|
Genina, N. |
|
2008 |
34 |
1S |
p. S30- 1 p. |
artikel |
8 |
Applications of lipidomics in pharmaceutical R&D
|
Ekroos, Kim |
|
2008 |
34 |
1S |
p. S22-S23 2 p. |
artikel |
9 |
Applying PAT in reactive crystallization
|
Alatalo, H. |
|
2008 |
34 |
1S |
p. S28- 1 p. |
artikel |
10 |
A simple gene delivery method for in vitro studies
|
Reinisalo, M. |
|
2008 |
34 |
1S |
p. S36- 1 p. |
artikel |
11 |
A solid-state NMR study of physical stability and molecular interactions in citric acid and paracetamol blends
|
Hoppu, P. |
|
2008 |
34 |
1S |
p. S38- 1 p. |
artikel |
12 |
Author Index
|
|
|
2008 |
34 |
1S |
p. S42-S45 4 p. |
artikel |
13 |
Automation of three different cellular assays on robotic workstation—Feasibility evaluation
|
Soikkeli, A. |
|
2008 |
34 |
1S |
p. S41- 1 p. |
artikel |
14 |
Betulin derivatives inhibit Alphavirus replication
|
Pohjala, L. |
|
2008 |
34 |
1S |
p. S40- 1 p. |
artikel |
15 |
Biocompatibility of mesoporous silicon microparticles
|
Santos, H.A. |
|
2008 |
34 |
1S |
p. S36-S37 2 p. |
artikel |
16 |
Biomarker discovery from mass spectral profiles: A combined proteomics and multivariate analysis
|
Rajalahti, Tarja |
|
2008 |
34 |
1S |
p. S27- 1 p. |
artikel |
17 |
Building the quality into manufacturing of macromolecular systems
|
Rantanen, Jukka |
|
2008 |
34 |
1S |
p. S11- 1 p. |
artikel |
18 |
CDNF is a novel neurotrophic factor for dopaminergic neurons in vivo
|
Voutilainen, Merja H. |
|
2008 |
34 |
1S |
p. S9- 1 p. |
artikel |
19 |
Chemistry and biochemistry of COMT inhibitors
|
Nissinen, Erkki |
|
2008 |
34 |
1S |
p. S7-S8 2 p. |
artikel |
20 |
Comparative studies of dopamine agonists and other therapies
|
Keränen, Tapani |
|
2008 |
34 |
1S |
p. S13- 1 p. |
artikel |
21 |
Computer-aided design and optimisation for pharmaceutical formulations
|
Takayama, Kozo |
|
2008 |
34 |
1S |
p. S10- 1 p. |
artikel |
22 |
Controlled drug release from crosslinked poly(ester-anhydrides)
|
Mönkäre, J. |
|
2008 |
34 |
1S |
p. S35-S36 2 p. |
artikel |
23 |
Controlled release of peptide from thermally hydrocarbonized mesoporous silicon microparticles in vivo
|
Kilpeläinen, M. |
|
2008 |
34 |
1S |
p. S35- 1 p. |
artikel |
24 |
Control of crystal nucleation: Insights from molecular simulation
|
Anwar, Jamshed |
|
2008 |
34 |
1S |
p. S11- 1 p. |
artikel |
25 |
Cost-effectiveness in Swedish reimbursement decision making
|
Engström, Andreas |
|
2008 |
34 |
1S |
p. S12- 1 p. |
artikel |
26 |
3D drug concentration distribution motoring during USP2 dissolution testing
|
Rimpiläinen, V. |
|
2008 |
34 |
1S |
p. S31-S32 2 p. |
artikel |
27 |
Design, synthesis and evaluation of novel prodrugs of metformin having improved lipophilicity
|
Huttunen, K.M. |
|
2008 |
34 |
1S |
p. S38- 1 p. |
artikel |
28 |
Desorption atmospheric pressure photoionization-mass spectrometry in drug analysis
|
Luosujärvi, Laura |
|
2008 |
34 |
1S |
p. S29- 1 p. |
artikel |
29 |
Determination of batch-to-batch variation for fluidized bed granulation
|
Matero, S. |
|
2008 |
34 |
1S |
p. S31- 1 p. |
artikel |
30 |
Developing an extended compartmental absorption and transit model for per oral controlled drug delivery
|
Marvola, J. |
|
2008 |
34 |
1S |
p. S39- 1 p. |
artikel |
31 |
Discovery of dopamine glucuronide in brain microdialysis samples using liquid chromatography tandem mass spectrometry
|
Uutela, P. |
|
2008 |
34 |
1S |
p. S33-S34 2 p. |
artikel |
32 |
Dissolution monitoring of hydrophilic matrix tablets by using frequency information of ultrasound echo
|
Leskinen, Jari |
|
2008 |
34 |
1S |
p. S26- 1 p. |
artikel |
33 |
Drug dissolution studies on mesoporous silicon particles—A theoretical approach
|
Laaksonen, T. |
|
2008 |
34 |
1S |
p. S35- 1 p. |
artikel |
34 |
Drug polymorphism causes problems on reliable pharmaceutical solubility testing
|
Heikkilä, T. |
|
2008 |
34 |
1S |
p. S30- 1 p. |
artikel |
35 |
Drugs release from hydrodynamically balanced systems analyzed with data-mining procedures by artificial neural networks
|
Mendyk, Aleksander |
|
2008 |
34 |
1S |
p. S26-S27 2 p. |
artikel |
36 |
Editorial Board
|
|
|
2008 |
34 |
1S |
p. ii- 1 p. |
artikel |
37 |
Effect of chitosan coating on liposomal gene delivery system
|
Sahin, N. |
|
2008 |
34 |
1S |
p. S36- 1 p. |
artikel |
38 |
Effect of COMT gene disruption on extracellular dopamine concentration as measured by quantitative no-net-flux microdialysis
|
Tammimäki, Anne |
|
2008 |
34 |
1S |
p. S28- 1 p. |
artikel |
39 |
Effects of formulation parameters and drug–polymer interactions on drug release from starch acetate matrix tablets
|
Pajander, J. |
|
2008 |
34 |
1S |
p. S31- 1 p. |
artikel |
40 |
Effects of mixing in pharmaceutical product design
|
Bałdyga, Jerzy |
|
2008 |
34 |
1S |
p. S16- 1 p. |
artikel |
41 |
Experimental and alternative ways of drug treatment of Parkinson's disease
|
Kaakkola, Seppo |
|
2008 |
34 |
1S |
p. S14-S15 2 p. |
artikel |
42 |
Feasibility of silicon and silica based mesoporous materials for oral drug delivery applications
|
Hirvonen, Jouni |
|
2008 |
34 |
1S |
p. S21- 1 p. |
artikel |
43 |
Following the role of PPARs in controlling systemic metabolism by metabolomics
|
Griffin, Julian L |
|
2008 |
34 |
1S |
p. S22- 1 p. |
artikel |
44 |
Gene therapy for Parkinson's disease
|
Björklund, Anders |
|
2008 |
34 |
1S |
p. S14- 1 p. |
artikel |
45 |
Greener pharmaceuticals
|
Clark, James H. |
|
2008 |
34 |
1S |
p. S23-S24 2 p. |
artikel |
46 |
Green technology to boost production of natural extracts
|
Shikov, Alexander |
|
2008 |
34 |
1S |
p. S28- 1 p. |
artikel |
47 |
Hormonal regulation of COMT activity in rats
|
Schendzielorz, N. |
|
2008 |
34 |
1S |
p. S33- 1 p. |
artikel |
48 |
Hot stage extrusion as manufacturing tool for controlled release formulations
|
Vervaet, Chris |
|
2008 |
34 |
1S |
p. S15- 1 p. |
artikel |
49 |
Identification of novel CAR agonists for drug development
|
Vanamo, J. |
|
2008 |
34 |
1S |
p. S32- 1 p. |
artikel |
50 |
Importance of the two forms of catechol-O-methyltransferase (COMT) in l-dopa metabolism: a pharmacokinetic study in COMT knock-out mice and in mice lacking soluble COMT
|
Käenmäki, Mikko |
|
2008 |
34 |
1S |
p. S28- 1 p. |
artikel |
51 |
Improved insight into the dissolution behavior of amorphous drugs by in situ solid-state analysis
|
Savolainen, Marja |
|
2008 |
34 |
1S |
p. S27- 1 p. |
artikel |
52 |
In-line monitoring of granule properties in fluidized bed granulation processes using a novel PAT tool
|
Buschmüller, Caroline |
|
2008 |
34 |
1S |
p. S25- 1 p. |
artikel |
53 |
In silico screening of potential crystal growth inhibitors for the stabilization of amorphous structures
|
Pajula, K. |
|
2008 |
34 |
1S |
p. S40- 1 p. |
artikel |
54 |
Investigation of porosity of tablets using photoacoustic spectroscopy (PAS)
|
Kurki, Lauri |
|
2008 |
34 |
1S |
p. S26- 1 p. |
artikel |
55 |
L20 Chemical imaging of tablets—Background, concepts and perspectives for online control
|
Kessler, Rudolf W |
|
2008 |
34 |
1S |
p. S15- 1 p. |
artikel |
56 |
L15 Clinical trials with catechol-O-methyltransferase (COMT) inhibitors, entacapone and tolcapone
|
Myllylä, Vilho |
|
2008 |
34 |
1S |
p. S13- 1 p. |
artikel |
57 |
L24 Co-crystals: An emerging approach to improving properties of pharmaceutical solids
|
Mirza, Sabiruddin |
|
2008 |
34 |
1S |
p. S16-S17 2 p. |
artikel |
58 |
L25 Hurray for the chemical microarray—Massive parallel analysis of proteases, kinases and cells on glass slides
|
Bradley, Mark |
|
2008 |
34 |
1S |
p. S17- 1 p. |
artikel |
59 |
Linking medicine to metabolomics and proteomics
|
Karjalainen, Erkki J. |
|
2008 |
34 |
1S |
p. S23- 1 p. |
artikel |
60 |
L1 Modification of l-DOPA metabolism: Benefits and problems
|
Brooks, David J. |
|
2008 |
34 |
1S |
p. S7- 1 p. |
artikel |
61 |
L36 Pathway search engine for proteomics—Dream, fact or fiction?
|
Fung, E.M. |
|
2008 |
34 |
1S |
p. S21-S22 2 p. |
artikel |
62 |
L43 Pharmaceuticals in the environment—An environmental hazard?
|
Kronberg, Leif |
|
2008 |
34 |
1S |
p. S24- 1 p. |
artikel |
63 |
L7 PMR—Pharmaceutical Manufacturing Research
|
Yliruusi, Jouko |
|
2008 |
34 |
1S |
p. S10- 1 p. |
artikel |
64 |
L13 Recent trends in pharmacoeconomics: Needs and unmet needs
|
Lyles, Alan |
|
2008 |
34 |
1S |
p. S12- 1 p. |
artikel |
65 |
L31 Thermosensitive and biodegradable polymeric micelles with transient stability for targeted drug delivery
|
Hennink, Wim E. |
|
2008 |
34 |
1S |
p. S19- 1 p. |
artikel |
66 |
Materials and technologies for analytical microsystems
|
Franssila, Sami |
|
2008 |
34 |
1S |
p. S17- 1 p. |
artikel |
67 |
Mechanism of nonviral nucleic acid and gene delivery
|
Wagner, Ernst |
|
2008 |
34 |
1S |
p. S20- 1 p. |
artikel |
68 |
Microchip-based CE-ESI/MS analysis of biological molecules
|
Sikanen, T. |
|
2008 |
34 |
1S |
p. S37- 1 p. |
artikel |
69 |
Microchip ionization mass spectrometry in drug analysis
|
Kostiainen, Risto |
|
2008 |
34 |
1S |
p. S18- 1 p. |
artikel |
70 |
Microsystems for drug development and diagnostics
|
Siitari, Harri |
|
2008 |
34 |
1S |
p. S19- 1 p. |
artikel |
71 |
Microtomography imaging as a characterization tool for solid dosage forms
|
Kuosmanen, Marko |
|
2008 |
34 |
1S |
p. S26- 1 p. |
artikel |
72 |
Modulation of lipidic nanostructures by designer short peptide surfactants
|
Yaghmur, Anan |
|
2008 |
34 |
1S |
p. S29- 1 p. |
artikel |
73 |
Molecular modeling of prostate specific antigen (PSA) and the design of compounds modulating its activity
|
Härkönen, H.H. |
|
2008 |
34 |
1S |
p. S39- 1 p. |
artikel |
74 |
Monitoring solid-state transformations in theophylline-lactose granules during drying in the multipart microscale fluid bed powder processor
|
Kivikero, Niina |
|
2008 |
34 |
1S |
p. S25- 1 p. |
artikel |
75 |
Nanocrystallization of indomethacin by wet ball-milling technique
|
Kettunen, R. |
|
2008 |
34 |
1S |
p. S35- 1 p. |
artikel |
76 |
Nanostructure-initiator mass spectrometry
|
Siuzdak, Gary |
|
2008 |
34 |
1S |
p. S18- 1 p. |
artikel |
77 |
Neuroprotective effects of coadministration of HB-GAM and GDNF in a rat model of Parkinson's disease
|
Piltonen, Marjo |
|
2008 |
34 |
1S |
p. S9- 1 p. |
artikel |
78 |
Novel administration routes for levodopa and dopamine agonists
|
Nyholm, Dag |
|
2008 |
34 |
1S |
p. S13-S14 2 p. |
artikel |
79 |
Novel neurotrophic factors MANF and CDNF protect neurons in primary culture
|
Vilponen, L.L. |
|
2008 |
34 |
1S |
p. S34- 1 p. |
artikel |
80 |
Opportunities for digitally encoded microcarriers in pharmacy and cell-based assays
|
Fayazpour, Farzaneh |
|
2008 |
34 |
1S |
p. S29- 1 p. |
artikel |
81 |
Organizers and Advisory Board
|
|
|
2008 |
34 |
1S |
p. vii- 1 p. |
artikel |
82 |
Paradoxical co-existence of protective and toxic effects of quercetin in the same in vitro neurodegeneration model
|
Ossola, B. |
|
2008 |
34 |
1S |
p. S33- 1 p. |
artikel |
83 |
Particle size determination during fluid bed granulation—Challenges and opportunities
|
Närvänen, Tero |
|
2008 |
34 |
1S |
p. S12- 1 p. |
artikel |
84 |
PAT—Optimal prediction of properties by means of tailormade modelling of spectroscopic/chromatographic profiles
|
Kvalheim, Olav M. |
|
2008 |
34 |
1S |
p. S16- 1 p. |
artikel |
85 |
Permeability studies of coumarins with new modified Caco-2 cell model
|
Galkin, A. |
|
2008 |
34 |
1S |
p. S38- 1 p. |
artikel |
86 |
Physicochemical and pharmacokinetic properties of COMT inhibitors
|
Forsberg, Markus |
|
2008 |
34 |
1S |
p. S8- 1 p. |
artikel |
87 |
Predicting tablet film coating thickness using a novel small-scale rotating plate system
|
Römer, M. |
|
2008 |
34 |
1S |
p. S32- 1 p. |
artikel |
88 |
Preparation and characterization of piroxicam – hydroxypropyl methylcellulose acetate succinate microspheres
|
Czech, A. |
|
2008 |
34 |
1S |
p. S34- 1 p. |
artikel |
89 |
Process and systems integration through miniaturization—Functional tools for the future
|
Haswell, Steven J. |
|
2008 |
34 |
1S |
p. S5-S6 2 p. |
artikel |
90 |
Program
|
|
|
2008 |
34 |
1S |
p. S1-S4 4 p. |
artikel |
91 |
Prolyl oligopeptidase (POP), a multifunction protein
|
Gracía-Horsman, J.A. |
|
2008 |
34 |
1S |
p. S32-S33 2 p. |
artikel |
92 |
Proteomic microchips
|
Baumann, Marc |
|
2008 |
34 |
1S |
p. S18-S19 2 p. |
artikel |
93 |
Quantitation of two enhancers in a pharmaceutical gel by near infrared spectroscopy
|
Pohjanjoki, P. |
|
2008 |
34 |
1S |
p. S31- 1 p. |
artikel |
94 |
Quantitative ultrasonics creates value in pharma business: Characterization and actuation
|
Hæggström, Edward |
|
2008 |
34 |
1S |
p. S11-S12 2 p. |
artikel |
95 |
Retarding the kinetics of theophylline hydrate formation using pharmaceutical excipients
|
Miroshnyk, I. |
|
2008 |
34 |
1S |
p. S40- 1 p. |
artikel |
96 |
Role of inflammation in the pathogenesis of Parkinson's disease: Models, mechanisms, and therapeutic interventions
|
Hong, Jau-Shyong |
|
2008 |
34 |
1S |
p. S5- 1 p. |
artikel |
97 |
Salmeterol, a long-acting β2-adrenergic receptor agonist, is neuroprotective through inhibition of microglial NADPH oxidase
|
Qian, L. |
|
2008 |
34 |
1S |
p. S33- 1 p. |
artikel |
98 |
Salvia species as potential sources in the treatment of Alzheimer's disease
|
Dastmalchi, K. |
|
2008 |
34 |
1S |
p. S38- 1 p. |
artikel |
99 |
Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystal technology
|
Müller, Rainer H. |
|
2008 |
34 |
1S |
p. S20-S21 2 p. |
artikel |
100 |
Selective surface patterning with electric discharge
|
Suni, N. |
|
2008 |
34 |
1S |
p. S37- 1 p. |
artikel |
101 |
Selegiline mimicks preconditioning induction of the redox protein thioredoxin against MPP+-induced neurotoxicity
|
Chiueh, Chuang C. |
|
2008 |
34 |
1S |
p. S8-S9 2 p. |
artikel |
102 |
Self-microemulsifying drug delivery system as nanosystems for bioavailability enhancement of flavonoids in vitro
|
Shikov, Alexander |
|
2008 |
34 |
1S |
p. S29- 1 p. |
artikel |
103 |
Solvent-mediated solid phase transformations of carbamazepine—Effects of simulated intestinal fluid and fasted state simulated intestinal fluid
|
Lehto, P. |
|
2008 |
34 |
1S |
p. S39- 1 p. |
artikel |
104 |
Synthesis of in vitro non-toxic 2,2-bis(methylol)propionic acid (Bis-MPA) dendrimers
|
Ropponen, J. |
|
2008 |
34 |
1S |
p. S36- 1 p. |
artikel |
105 |
Systems biology in pharmaceutical R&D
|
Oresic, Matej |
|
2008 |
34 |
1S |
p. S23- 1 p. |
artikel |
106 |
System thinking and the future of medicine and personal health
|
van der Greef, Jan |
|
2008 |
34 |
1S |
p. S6- 1 p. |
artikel |
107 |
The effect of differentiation on the expression of UGT isoenzymes in Caco-2 cell line
|
Siissalo, S. |
|
2008 |
34 |
1S |
p. S40-S41 2 p. |
artikel |
108 |
The effect of mixing time of the magnesium stearate on crushing strengths of tablets
|
Virtanen, Satu |
|
2008 |
34 |
1S |
p. S27- 1 p. |
artikel |
109 |
Utilizing ion mobility spectrometry combined with mass spectrometry for analysis of pharmaceutical compounds
|
Mauriala, T. |
|
2008 |
34 |
1S |
p. S39-S40 2 p. |
artikel |